1. Home
  2. SNT vs VNRX Comparison

SNT vs VNRX Comparison

Compare SNT & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Senstar Technologies Ltd.

SNT

Senstar Technologies Ltd.

HOLD

Current Price

$4.60

Market Cap

95.2M

ML Signal

HOLD

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.27

Market Cap

38.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNT
VNRX
Founded
1965
N/A
Country
Canada
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
95.2M
38.2M
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
SNT
VNRX
Price
$4.60
$0.27
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$2.50
AVG Volume (30 Days)
68.4K
2.2M
Earning Date
11-25-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
257.88
N/A
EPS
0.21
N/A
Revenue
$37,837,000.00
$1,472,007.00
Revenue This Year
N/A
$55.98
Revenue Next Year
N/A
$420.37
P/E Ratio
$23.21
N/A
Revenue Growth
9.82
14.48
52 Week Low
$2.57
$0.22
52 Week High
$5.34
$0.94

Technical Indicators

Market Signals
Indicator
SNT
VNRX
Relative Strength Index (RSI) 63.29 45.05
Support Level $3.10 $0.22
Resistance Level $4.95 $0.26
Average True Range (ATR) 0.30 0.02
MACD 0.17 0.01
Stochastic Oscillator 81.13 60.42

Price Performance

Historical Comparison
SNT
VNRX

About SNT Senstar Technologies Ltd.

Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: